Target intelligence / Profile preview

RNA, U6 small nuclear 670, pseudogene (RNU6-670P)

Target
RNU6-670P
Molecular classification
Pseudogene, non-coding RNA-derived pseudogene
01

Overview

RNU6-670P, RNA, U6 small nuclear 670, pseudogene, is a nonfunctional genomic segment related to the U6 small nuclear RNA gene. U6 snRNA is a vital spliceosomal RNA involved in mRNA splicing within the nucleus, but pseudogenes like RNU6-670P are typically noncoding and do not produce functional RNA molecules. Pseudogenes are generally silent genomic fossils, although in rare cases they may regulate gene expression through sequence homology-based mechanisms. There is no evidence or functional annotation suggesting that RNU6-670P has biological activity as a protein, enzyme, receptor, or therapeutic target[6][1][2]. Pseudogenes such as RNU6-670P arise from duplication or retrotransposition of functional genes (here, U6 snRNA) but lose the ability to code for active RNA or protein[6]. The functional counterpart, U6 small nuclear RNA (RNU6-1), is one of the core snRNAs in the spliceosome and is required for pre-mRNA splicing, which is central to eukaryotic gene expression[1][4]. Multiple nonfunctional copies (pseudogenes) of snRNA genes, including U6, exist in vertebrate genomes and typically serve no known biological function[1][6]. No evidence suggests RNU6-670P is therapeutically relevant or disease-associated, nor does it possess properties that make it a molecular target for drugs. If structured information for drug target databases is required, this entry should be flagged as incorrect or non-target.

Other names
RNU6-670PRNA, U6 small nuclear 670, pseudogene
02

Mechanism of action

None. No mechanism of action pertains to this pseudogene.

03

Biological functions

None. Functional U6 snRNA is involved in RNA splicing, but the pseudogene does not perform this role.
04

Disease associations

None directly attributable. Functional U6 snRNA is important in splicing and may be involved in disease when dysregulated, but pseudogenes generally do not participate in disease mechanisms unless shown to act as competitive endogenous RNAs or by other rare mechanisms.
05

Safety considerations

None. There are no safety concerns directly tied to this pseudogene.
06

Interacting drugs

None. No drugs act on or interact with this pseudogene.
07

Biomarkers

None. The pseudogene is not used as a biomarker; however, the related functional U6 snRNA may serve as a normalization control or disease indicator in certain contexts.

Beyond the preview

Go deeper on RNA, U6 small nuclear 670, pseudogene (RNU6-670P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 670, pseudogene (RNU6-670P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call